Corrigendum to "CD4+CD25+CD127low regulatory T cells associated with the effect of CD19 CAR-T therapy for relapsed/refractory B-cell acute lymphoblastic leukemia" [Int. Immunopharmacol. 96 (2021) 107742]
Int Immunopharmacol. 2022 Jan:102:108194.
doi: 10.1016/j.intimp.2021.108194.
Epub 2021 Oct 13.
1 Hematology Department, the Second Hospital of Anhui Medical University (SHAMU), Hefei, Anhui Province, China; Hematologic Diseases Research Center of Anhui Medical University, Hefei, Anhui Province, China.
2 Hematologic Diseases Research Center of Anhui Medical University, Hefei, Anhui Province, China.
3 Hematology Department, the Second Hospital of Anhui Medical University (SHAMU), Hefei, Anhui Province, China; Hematologic Diseases Research Center of Anhui Medical University, Hefei, Anhui Province, China. Electronic address: zzzm889@163.com.